SCHEMBL6940326

SCHEMBL6940326

B.B.B.B.[Zn]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL193287 1.00
SCHEMBL29286240 0.82
SCHEMBL11444381 0.82
SCHEMBL28744622 0.82
SCHEMBL6925632 0.82
SCHEMBL25264473 0.82
Fluoride SCHEMBL9347241 0.82
Water SCHEMBL5076495 0.82
Fluoride SCHEMBL7528382 0.82
SCHEMBL28492502 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106467464-B (E) -2-isopropyl-5-methyl-3, 5-hexadienoic acid ester compound and production method and application thereof 信越化学工业株式会社 2020-12-29 CN disclosed
US-6583119-B2 Aromatic antibiotics such as 7-((6-deoxy-5-methyl-4-methyl-hexopyranosyl)oxy)-4-hydroxy-8-methyl-3-(1 -(phenoxyimino) ethyl)-2H-1-benzopyran-2-one (2-propynyloxy)-carbamic 3'-ester acid, for prevention of grampositive bacterial infections AVENTIS PHARMA S.A. (FR) 2003-06-24 US disclosed
US-20030060609-A1 Novel aromatic amides, preparation method and application as medicines AVENTIS PHARMA S.A. 2003-03-27 US disclosed
US-6420538-B1 COMPOUND FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS AVENTIS PHARMA S.A. (FR) 2002-07-16 US disclosed